A citation-based method for searching scientific literature

Erin Hofstatter, Karishma Mehra, Melinda Yushak, Lajos Pusztai. Future Oncol 2015
Times Cited: 3







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
198
66

Revealing the incidentalome when targeting the tumor genome.
Yvonne Bombard, Mark Robson, Kenneth Offit. JAMA 2013
46
66

Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.
F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, A M Bailey, L Strong, K Shaw, K Lu, Y Qi, H Zhao,[...]. Ann Oncol 2016
83
66

Cancer Genetic Counselors' Current Practices and Attitudes Related to the Use of Tumor Profiling.
LeAnne Noelle Goedde, Nathan W Stupiansky, Melissa Lah, Kimberly A Quaid, Stephanie Cohen. J Genet Couns 2017
10
66

The genomic landscape of small intestine neuroendocrine tumors.
Michaela S Banck, Rahul Kanwar, Amit A Kulkarni, Ganesh K Boora, Franziska Metge, Benjamin R Kipp, Lizhi Zhang, Erik C Thorland, Kay T Minn, Ramesh Tentu,[...]. J Clin Invest 2013
178
33


Smad4 inactivation promotes malignancy and drug resistance of colon cancer.
Panagiotis Papageorgis, Kuanghung Cheng, Sait Ozturk, Yi Gong, Arthur W Lambert, Hamid M Abdolmaleky, Jin-Rong Zhou, Sam Thiagalingam. Cancer Res 2011
132
33

Targeted modulation of MGMT: clinical implications.
Lili Liu, Stanton L Gerson. Clin Cancer Res 2006
175
33

Neuroendocrine tumors of the lung: an update.
Natasha Rekhtman. Arch Pathol Lab Med 2010
240
33

Onco-proteogenomics: cancer proteomics joins forces with genomics.
Javier A Alfaro, Ankit Sinha, Thomas Kislinger, Paul C Boutros. Nat Methods 2014
89
33


Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
Randi J A LaPoint, Patricia A Bourne, Hanlin L Wang, Haodong Xu. Appl Immunohistochem Mol Morphol 2007
27
33



Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
S X Jiang, T Kameya, Y Sato, N Yanase, H Yoshimura, T Kodama. Am J Pathol 1996
78
33


Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
Federica Di Nicolantonio, Miriam Martini, Francesca Molinari, Andrea Sartore-Bianchi, Sabrina Arena, Piercarlo Saletti, Sara De Dosso, Luca Mazzucchelli, Milo Frattini, Salvatore Siena,[...]. J Clin Oncol 2008
33

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Sandip P Patel, Maria Schwaederle, Gregory A Daniels, Paul T Fanta, Richard B Schwab, Kelly A Shimabukuro, Santosh Kesari, David E Piccioni, Lyudmila A Bazhenova, Teresa L Helsten,[...]. Oncotarget 2015
13
33

Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
Sandrine Faivre, Marie-Paule Sablin, Chantal Dreyer, Eric Raymond. Endocrinol Metab Clin North Am 2010
20
33

The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
David S Klimstra, Himisha Beltran, Rogerio Lilenbaum, Emily Bergsland. Am Soc Clin Oncol Educ Book 2015
23
33

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Ilaria Marinoni, Anja Schmitt Kurrer, Erik Vassella, Matthias Dettmer, Thomas Rudolph, Vanessa Banz, Fabio Hunger, Silvan Pasquinelli, Ernst-Jan Speel, Aurel Perren. Gastroenterology 2014
233
33


Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.
Zhi Rong Qian, Monica Ter-Minassian, Jennifer A Chan, Yu Imamura, Susanne M Hooshmand, Aya Kuchiba, Teppei Morikawa, Lauren K Brais, Anastassia Daskalova, Rachel Heafield,[...]. J Clin Oncol 2013
63
33

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Shinichi Yachida, Efsevia Vakiani, Catherine M White, Yi Zhong, Tyler Saunders, Richard Morgan, Roeland F de Wilde, Anirban Maitra, Jessica Hicks, Angelo M Demarzo,[...]. Am J Surg Pathol 2012
287
33


Special Review: Caught in the Crosshairs: Targeted Drugs and Personalized Medicine.
Bibiana I Ferreira, Richard Hill, Wolfgang Link. Cancer J 2015
5
33


Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
Hiroaki Komatsu, Anna Kakehashi, Noritoshi Nishiyama, Nobuhiro Izumi, Shinjiro Mizuguchi, Shotaro Yamano, Hidetoshi Inoue, Shoji Hanada, Kyukwang Chung, Min Wei,[...]. Cancer Biomark 2013
9
33

Biomarkers in pancreatic neuroendocrine tumors.
Maria Serafeim Theochari, Konstantinos N Syrigos, Muhammad Wasif Saif. JOP 2014
3
33

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids.
Lynnette Fernandez-Cuesta, Martin Peifer, Xin Lu, Ruping Sun, Luka Ozretić, Danila Seidal, Thomas Zander, Frauke Leenders, Julie George, Christian Müller,[...]. Nat Commun 2014
157
33

A new dimension of FDG-PET interpretation: assessment of tumor biology.
Thomas C Kwee, Sandip Basu, Babak Saboury, Valentina Ambrosini, Drew A Torigian, Abass Alavi. Eur J Nucl Med Mol Imaging 2011
61
33

Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.
Christian Geis, Volker Fendrich, Peter Rexin, Pietro Di Fazio, Detlef K Bartsch, Matthias Ocker, Karl Quint, Anna E Heverhagen. J Surg Res 2015
6
33

MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.
Dorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, Wim Van Criekinge, Manon van Engeland, Gaia Gatti, Mieke E R Henfling, Mauro Papotti, Aurel Perren, Frans C S Ramaekers,[...]. J Clin Endocrinol Metab 2014
34
33

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.
Hugo J W L Aerts, Emmanuel Rios Velazquez, Ralph T H Leijenaar, Chintan Parmar, Patrick Grossmann, Sara Carvalho, Johan Bussink, René Monshouwer, Benjamin Haibe-Kains, Derek Rietveld,[...]. Nat Commun 2014
33

A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging.
Andrew J Buckler, Linda Bresolin, N Reed Dunnick, Daniel C Sullivan. Radiology 2011
107
33

Neuroendocrine neoplasms of the gastrointestinal tract.
Matthias Schott, Günter Klöppel, Andreas Raffel, Andreas Saleh, Wolfram Trudo Knoefel, Werner A Scherbaum. Dtsch Arztebl Int 2011
33
33

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
Sara Ekeblad, Anders Sundin, Eva Tiensuu Janson, Staffan Welin, Dan Granberg, Henrik Kindmark, Kristina Dunder, Gordana Kozlovacki, Håkan Orlefors, Mattias Sigurd,[...]. Clin Cancer Res 2007
317
33

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.
Edoardo Missiaglia, Irene Dalai, Stefano Barbi, Stefania Beghelli, Massimo Falconi, Marco della Peruta, Lorenzo Piemonti, Gabriele Capurso, Alessia Di Florio, Gianfranco delle Fave,[...]. J Clin Oncol 2010
379
33

Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Joakim Crona, Tobias Gustavsson, Olov Norlén, Katarina Edfeldt, Tobias Åkerström, Gunnar Westin, Per Hellman, Peyman Björklund, Peter Stålberg. Ann Surg Oncol 2015
38
33

Apoptosis in cancer: cause and cure.
S H Kaufmann, G J Gores. Bioessays 2000
153
33

Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.
Stéphane Collaud, Verena Tischler, Andrej Atanassoff, Thomas Wiedl, Paul Komminoth, Christian Oehlschlegel, Walter Weder, Alex Soltermann. BMC Cancer 2015
10
33

Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.
Laura Catena, Emilio Bajetta, Massimo Milione, Monika Ducceschi, Monica Valente, Francesca Dominoni, Valentina Colonna. Target Oncol 2011
24
33

TP53 mutations in human cancers: origins, consequences, and clinical use.
Magali Olivier, Monica Hollstein, Pierre Hainaut. Cold Spring Harb Perspect Biol 2010
904
33

Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization.
Monica Sager, Nai Chien Yeat, Stefan Pajaro-Van der Stadt, Charlotte Lin, Qiuyin Ren, Jimmy Lin. Expert Rev Mol Diagn 2015
16
33

Biomarkers and surrogate endpoints.
J K Aronson. Br J Clin Pharmacol 2005
120
33

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
J K Ramage, A H G Davies, J Ardill, N Bax, M Caplin, A Grossman, R Hawkins, A M McNicol, N Reed, R Sutton,[...]. Gut 2005
273
33


GEPNETs update: Radionuclide therapy in neuroendocrine tumors.
Wouter A van der Zwan, Lisa Bodei, Jan Mueller-Brand, Wouter W de Herder, Larry K Kvols, Dik J Kwekkeboom. Eur J Endocrinol 2015
79
33

Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.
George Miles, James Rae, Suresh S Ramalingam, John Pfeifer. Semin Oncol 2015
5
33

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Gideon M Blumenthal, Elizabeth Mansfield, Richard Pazdur. JAMA Oncol 2016
31
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.